We offer a complete program of preclinical research services to support a range of your toxicology requirements. We have experience with early assessment of new molecules including single dose, multiple dose and targeted studies, as well as directed or investigative toxicology, IND-enabling toxicology programs and long-term carcinogenicity studies.

You will find our PhD study directors to be experienced scientists who are communicative, collaborative and attentive, and you can count on us to deliver high-quality GLP reports on time, every time.

Due to our unique and extensive experience in preclinical studies and state-of-the-art facilities, we have the skill and expertise to accelerate new drugs, small molecules, metals, biologics, stem cells, nanoparticles, and devices from discovery through the drug development process, to regulatory submission and studies in man.  We offer unique and sophisticated methods of assessment including OCT, laser doppler, ELISA, immunohistochemistry, and Silhouette photography.

Dermal toxicology study expertise at CBI includes:

  • Skin irritation studies to intact or abraded skin
  • Acute (LD50) dermal toxicity study in rats or rabbits
  • Acute single or multiple dose dermal toxicity studies in rodents
  • Acute single or multiple dose dermal toxicity studies in minipig or other nonrodent species
  • Two week dermal toxicity studies in rodents
  • Two week dermal toxicity studies in minipig or other nonrodent
  • Four week dermal toxicity studies in rodents (with or without recovery period)
  • Four week dermal toxicity studies in minipig or other nonrodent(with or without recovery period)
  • 3, 6, or 12 month dermal toxicity studies in rodents (with or without recovery period)
  • 3, 6, or 12 month dermal toxicity studies in minipig or other nonrodent(with or without recovery period)
  • Acute perivascular irritation study in rabbits
  • Hypersensitization studies
  • Phototoxicity and UV light